During the past decade, Renaissance Clinical Research and Hypertension Clinic conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 6 clinical trials were completed, i.e. on average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Renaissance Clinical Research and Hypertension Clinic" #1 sponsor was "AstraZeneca" with 2 trials, followed by "Teva Branded Pharmaceutical Products R&D, Inc." with 2 trials sponsored, "BioCryst Pharmaceuticals" with 1 trials sponsored, "Braeburn Pharmaceuticals" with 1 trials sponsored and "Depomed" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Renaissance Clinical Research and Hypertension Clinic" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Camurus AB" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Renaissance Clinical Research and Hypertension Clinic" are "Chronic Pain" (4 trials), "Type 2 Diabetes" (2 trials), "Chronic Lower Back Pain" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Genital Herpes" (1 trials). Many other conditions were trialed in "Renaissance Clinical Research and Hypertension Clinic" in a lesser frequency.

Most popular intervention types in "Renaissance Clinical Research and Hypertension Clinic" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Dapagliflozin" (2 trials), "Hydrocodone ER" (2 trials), "BCX4208" (1 trials) and "Famciclovir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Renaissance Clinical Research and Hypertension Clinic" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Renaissance Clinical Research and Hypertension Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Renaissance Clinical Research and Hypertension Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Renaissance Clinical Research and Hypertension Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".